Please login to the form below

Not currently logged in
Email:
Password:

Endocyte appoints Parexel's Scot Harper to oversee clinical trials

He also previously served at Novartis and Lilly

Scot Harper, Endocyte Endocyte has appointed Dr Scot Harper as VP, clinical operations, where he will be responsible for clinical trial operations at the US biopharma company.

Dr Harper (pictured right) joins from clinical research organisation (CRO) Parexel, where he held the role of global portfolio director for oncology, overseeing clinical activities for cancer drugs from phase I to IV development.

He also has experience working in clinical operations for major pharma companies, serving as VP of Novartis' North American clinical operations, and senior director of clinical operations at Lilly.

Prior to this, Dr Harper worked in new product development at SmithKline Beechham.

Endocyte, which focuses on developing therapies for the treatment of cancer and other serious diseases, will benefit from his experience of working on the development of major oncology brands like Tasigna and Gleevec.

“Scot has deep expertise in the drug development process and management of all stages of clinical trials, and he will play a key role at Endocyte as we seek to expand and advance our platform,” said Ron Ellis, Endocyte's president and CEO, referencing the development of oncology candidates vintafolide and etarfolatide, which are in phase III and phase II trials respectively.

In addition, Endocyte says it has three new drug candidates scheduled to enter the clinic before the end of 2014.

9th May 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...